† Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States ‡ Lilly Research Center, A Division of Eli Lilly and Company, Erl ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has announced promising results from its Phase 2 trial of NBI-1117568, a first-in-class investigational oral muscarinic M4 selective agonist for ...

Format – Fireside chat and one-on-one investor meetings Date and Time – Wednesday, June 11, 2025, at 8:40am ET / 5:40am PT Live webcasts of the data release, as well as the presentation ...

The first Splitgate was a hit, combining the fast-paced arena action of Halo with the strategy of Portal, and the sequel, Splitgate 2, has arrived in Open Beta, but server issues disrupted the launch.

I've been eagerly awaiting the Splitgate 2 open beta for a while. Set to stay live until it fully launches in the summer, it's an endless opportunity to play my most anticipated new FPS game ...

Estrogen receptor β (ERβ) selective agonists are considered potential therapeutic agents ... that arise from alternative splicing of the last exon coding for ERβ. (2) Nevertheless, the only fully ...

AC-201, a selective TYK2/JAK1 inhibitor with therapeutic potential across a broad range of immune mediated inflammatory diseases, has completed a phase 2 clinical trial in Psoriasis with first-rate ...